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Abstract: The physicochemical and biological properties of
calcium silicate-based cement (CS) associated to microparti-
culated (micro) or nanoparticulated (nano) zirconium oxide
(ZrO2) were compared with CS and bismuth oxide (BO) with
CS. The pH, release of calcium ions, radiopacity, setting time,
and compression strength of the materials were evaluated.
The tissue reaction promoted by these materials in the sub-
cutaneous was also investigated by morphological, immuno-
histochemical, and quantitative analyses. For this purpose,
polyethylene tubes filled with materials were implanted into
rat subcutaneous. After 7, 15, 30, and 60 days, the tubes sur-
rounded by capsules were fixed and embedded in paraffin. In
the H&E-stained sections, the number of inflammatory cells
(ICs) in the capsule was obtained. Moreover, detection of
interleukin-6 (IL-6) by immunohistochemistry and number of
IL-6 immunolabeled cells were carried out. von Kossa
method was also performed. The differences among the
groups were subjected to Tukey test (p0.05). The solutions
containing the materials presented an alkaline pH and
released calcium ions. The addition of radiopacifiers
increased setting time and radiopacity of CS. A higher com-
pressive strength in the CS1ZrO2 (micro and nano) was
found compared with CS1BO. The number of IC and IL-6
positive cells in the materials with ZrO2 was significantly
reduced in comparison with CS1BO. von Kossa-positive
structures were observed adjacent to implanted materials.
The ZrO2 associated to the CS provides satisfactory physico-
chemical properties and better biological response than BO.
Thus, ZrO2 may be a good alternative for use as radiopacify-
ing agent in substitution to BO. VC 2014 Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 102A: 4336–4345, 2014.
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INTRODUCTION
Mineral trioxide aggregate (MTA) has been widely recom-
mended in dentistry for pulp capping, pulpotomy, apical
barrier formation in teeth with necrotic pulps and open
apexes, repair of root perforations, and root-end ﬁlling due
to its marginal adaptation and biocompatibility.1,2 This
material is basically composed by Portland cement (PC), a
calcium silicate-based material (CS) added to a radiopacify-
ing agent, bismuth oxide (BO), in a 4:1 proportion.3 It has
been reported that PC exhibits biocompatibility and high
compressive strength allowing that this material may be
also suitable for medical indications, such as in orthopedic
applications.4
Studies have been demonstrated that the addition of
20% BO to PC confers high radiopacity5–7 but interferes in
some properties of the material.8–10 Evidence suggests that
BO interferes with the hydration mechanism of MTA and
precipitation of calcium hydroxide in the hydrated paste.9
Furthermore, the association of BO dramatically changes the
microstructure of the cement by acting as ﬂaws within the
cement matrix8 and, consequently, increases the porosity
and solubility of the PC culminating in the reduction of its
resistance.8–11 Regarding the biocompatibility, it has been
shown that BO interferes with cell growth12 and, in human
dental pulp cell cultures, increases the cytotoxicity of the
material.13
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So, other high molecular mass materials have been stud-
ied as alternatives radiopaciﬁers agents5–7,14 to be added to
MTA. One of these materials is zirconium oxide (ZrO2)
which was initially introduced as a biomaterial in orthope-
dic surgery due to its hardness, high density, and good wear
resistance. More recently, it has been related that ZrO2
added to PC in a 1:4 ratio provides an adequate radiopacity,
that is, superior to the recommended by ISO 6876 speciﬁca-
tion for dental root canal sealing materials.5,6 There is evi-
dence that this mixture releases calcium ions and provides
to the microenvironment an alkaline pH.7 Moreover, studies
have been shown that the addition of 30% ZrO2 does not
affect the hydration reaction of PC and originates a bioactive
cement15 with comparable properties with MTA.14
It has been suggested that the reduction in the material
particle size could improve the physicochemical properties
of MTA due to its rapid hydration.16 MTA-based material
composed by small particles exhibits reduced setting time
and increased microhardness.17 It has been demonstrated
that ZrO2, in its nanoparticulated form, presents bioactivity,
cytocompatibility,18 and high resistance.19 However, the
effects of nanoparticulated ZrO2 on the properties of CSs
are unknown.
Thus, the aim of this study was to evaluate some physi-
cochemical properties such as pH, release of calcium ions,
radiopacity, setting time, and compression strength of a CS,
PC, associated to 30% microparticulated or nanoparticu-
lated ZrO2 in comparison with CS and CS added to BO. Fur-
thermore, the tissue reaction promoted by these materials
in the rat subcutaneous was investigated by morphological,
immunohistochemical, and quantitative analyses.
MATERIALS AND METHODS
In this study, the following materials were tested: CS (White
Portland cement; CPB-40—Votorantin Cimentos, Camargo
Correa S.A., Pedro Leopoldo, MG, Brazil), CS group; CS with
BO (Sigma Aldrich, St. Louis, MO), CS1BO group; CS with
microparticulated ZrO2 (Sigma Aldrich, St. Louis, MO),
CS1 ZrO2 micro group and CS with nanoparticulated ZrO2,
CS1 ZrO2nano group. The powder (CS, CS1BO, CS1 ZrO2
micro, and CS1 ZrO2nano) was previously sterilized by
ultraviolet method for 30 min. A ratio of 20% BO and 80%
CS and 30% ZrO2 and 70% CS by weight were used for
analyses. The materials were mixed at a ratio of 1 g powder
of cement per 0.3 mL liquid (distilled water) as previously
described.5,7,13,14 Regarding to CS1 ZrO2, it has been dem-
onstrated that this powder/liquid proportion provides a
material with comparable properties to MTA14 and does not
interfere in the hydration reaction of calcium silicate
cement.15 Moreover, the CS1 ZrO2nano was prepared using
a powder:liquid mixing ratio of 1 g:0.33 mL, standardized in
pilot tests, because it provided a thicker consistency to the
nanoparticulated cement in comparison to the other materi-
als, easier to handle, and to insert in the polyethylene tubes.
Thus, this proportion provided an adequate handling and
consistency characteristics for a cement intended for use as
a root-end ﬁlling material. Nanoparticulated ZrO2 was per-
formed by polymeric precursor method at Institute of
Physics of S~ao Carlos (University of S~ao Paulo, S~ao Carlos,
Brazil); the particle size obtained was 74 nm which was
conﬁrmed by Brunauer-Emmett-Teller surface area analysis.
Analyses of the pH and calcium ion release
The pH and calcium ion release were evaluated according to
methodology performed by Vivan et al.20 and Duarte et al.7
Ten polyethylene tubes (Embramed Ind. Com., S~ao Paulo, SP,
Brazil) measuring 10.0 mm length and 1.6 mm diameter
were ﬁlled with freshly prepared samples of each material,
sealed in ﬂasks containing 10 mL of distilled water, and
stored at 37C. After 1 day of immersion, the tubes were
carefully removed and placed into new ﬂasks with an equal
amount of distilled water, and this procedure was repeated
after 7, 14, and 28 days. The solutions pH was analyzed at
each period using a previously calibrated digital pH meter
(Ultrabasic; Denver Instrument Company, Arvada, CO). The
same solutions used to test pH were used to test for cal-
cium ion release. At the same periods, the calcium ions
released in the distilled water was measured using an
atomic absorption spectrophotometer (H1170 Hilger &
Watts; Rank Precision Industries, Analytical Division, Lon-
don, UK). The concentration of calcium ions released from
the materials was quantiﬁed using a calcium hollow cathode
lamp (422.7-nm wavelength and 0.7-nm window) operated
at 20 mA. The readings of calcium ion release were com-
pared with a standard curve obtained from multiple dilu-
tions of pure calcium in ultrapure water.
Radiopacity
The specimens used for radiopacity test were prepared
according to the ISO 6876/200121 standard for dental root-
sealing materials. Five specimens, measuring 10 mm diame-
ter by 1.0 mm thickness, were made for each tested mate-
rial. The specimens were stored at 37C for 24 h, and
subsequently, they were positioned on ﬁve occlusal radio-
graphic ﬁlms (Insight-Kodak Comp, Rochester, NY) and
exposed, along with an aluminum stepwedge with variable
thickness (from 2 to 16 mm, in 2-mm increments) as
described by Bortoluzzi et al.5 and Duarte et al.6 A GE-1000
X-ray unit (General Electric, Milwaukee, WI) operating at 50
kVp, 10 mA, 18 pulses/s, and focus-ﬁlm distance of 33.5 cm
was used. The ﬁlms were processed in a standard automatic
processor (Dent-X 9000, Dent-X, Elmsford, USA). Radio-
graphs were digitized using a desktop scanner (SnapScan
1236-Agfa, Deutschland) and the digitized images were
imported to the Image Tool 3.0 (UTHSCSA, San Antonio,
TX); an equal-density tool was used to identify equal-
density areas in the radiographic images.5,6 This procedure
allowed comparison between the radiographic density of
the cements and the radiopacity of the different aluminum
stepwedge thicknesses. The area corresponding to the speci-
men was selected in each radiographic image to verify the
thickness of the aluminum stepwedge detected by the soft-
ware as equivalent to the material’s radiographic density.
Thus, the radiopacity of the evaluated materials was esti-
mated from the thickness of aluminum (in mm) by using a
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conversion equation.6 The values recorded for each material
were averaged to obtain a single value in mm Al.
Setting time
This test was carried out as determined by #57 of American
Dental Association22 and C266-03 of American Society for
Testing and Materials.23 Six specimens measuring 10 mm
diameter and 2 mm in height were made per each material.
At 1206 10 s after the onset of mixture, the assembly was
placed in a well-sealed plastic ﬂask and stored in an oven
at 37C and 95% relative humidity. After 1506 10 s to the
onset of mixture, a Gilmore needle of 1006 0.5 g and active
tip of 2.06 0.1 mm diameter was vertically placed on the
cement surface. This procedure was repeated at 60-s inter-
vals. The initial setting time of the cement was considered
as the time between the onset of mixture and the moment
when the marks of needles could not be observed on the
cement surface. Concerning the ﬁnal setting time, a Gilmore
needle of 45660.5 g and active tip of 1.06 0.1 mm diame-
ter were used as previously described. The initial and ﬁnal
setting times were determined by the arithmetic mean of
six repetitions of the test for each group.24
Compression strength
To test the compression strength, specimens measuring 12
mm in height by 6 mm in diameter were made according to
ISO 9917-1/2003.25 Six specimens were used in each group;
these specimens were maintained at 37C under 100% rela-
tive humidity until the tests were performed. The specimens
were subjected to testing at 24 h, 7, 14, 21, and 28 days
after-manipulation of the cements10 using an universal test-
ing machine (EMIC DL 2000, Curitiba, PR, Brazil), at a speed
of 0.5 mm/min and load of 5 kN. All measurements were
recorded in kg and converted to megapascal (MPa).
Tissue reaction
The research protocol on animal use of this study was
authorized by the Ethical Committee for Animal Research of
the S~ao Paulo State University, Brazil (CEUA n 26/2010-
Araraquara Dental School-UNESP). Sixty male Holtzman rats
(Rattus norvegicus albinus) weighing 250610 g were used.
The rats were maintained in individual stainless steel cages
under a 12:12 light-dark cycle at a controlled temperature
(236 2C) and humidity (556 10%), with food and water
provided ad libitum.
The animals were distributed into ﬁve groups according
the evaluated materials (n5 5 per group in each period).
The polyethylene tubes (Embramed Ind. Com., Sao Paulo, SP,
Brazil) with 10.0 mm length and 1.6 mm diameter, previ-
ously sterilized with ethylene oxide, were ﬁlled with CS (CS
group), CS with BO (CS1BO group), CS with microparticu-
lated ZrO2 (CS1 ZrO2micro group) or CS with nanoparticu-
lated ZrO2 (CS1 ZrO2nano group), and control group (CG),
empty polyethylene tubes. After mixing of the materials, the
polyethylene tubes were ﬁlled and immediately implanted
into the dorsal subcutaneous. In each rat, two polyethylene
tubes, ﬁlled with different materials each, were implanted in
the subcutaneous; in control group (CG), two empty poly-
ethylene tubes were placed in the subcutaneous. Thus, ﬁve
polyethylene tubes were analyzed per group in each experi-
mental period.
The animals were anesthetized with an intraperitoneal
injection of ketamine (80 mg/kg of body weight) combined
with xylazine (4 mg/kg of body weight). The dorsal skin
was shaved and disinfected with 5% iodine solution. Subse-
quently, a 20-mm-long incision was made using a scalpel
(n 15, Fibra Cirurgica, Joinvile, SC, Brazil) and two polyeth-
ylene tubes, each ﬁlled with one of the materials, were
placed into the subcutaneous pockets. After 7, 15, 30, and
60 days of implantation, the tubes surrounded by connec-
tive tissue were removed and the specimens were processed
for parafﬁn embedding. The analysis at 7 and 15 days was
conducted to evaluate the initial reaction induced by materi-
als as well as the kind of inﬂammatory cells (ICs) observed
in the capsules. The prolonged periods (30 and 60 days)
were used to evaluate if the materials implanted allow that
ICs would be replaced by ﬁbroblasts and collagen ﬁbers.
Histological procedures
The specimens were ﬁxed in 4% formaldehyde (prepared
from paraformaldehyde) buffered at pH 7.2 with 0.1M
sodium phosphate for 48 h at room temperature. Subse-
quently, the specimens were dehydrated and embedded in
parafﬁn. Longitudinal sections, 6 mm thick, were stained
with hematoxylin & eosin (H&E) for morphological analysis.
H&E-stained sections were also used to estimate the num-
ber of ICs in the capsule. Sections were submitted to the
von Kossa histochemical method, for detection of calciﬁed
structures in the connective tissue adjacent to the implanted
materials. Sections were also adhered to silanized slides for
interleukin-6 (IL-6) immunohistochemical reaction.
Numerical density of inﬂammatory cells. The numerical
density of ICs was undertaken using a light microscope
(BX51, Olympus, Tokyo, Japan) and an image analysis sys-
tem (Image Pro-Express 6.0, Olympus) as previously
described.26 In each implant, three H&E-stained sections of
the capsule were selected at intervals of at least 100 mm. In
each section, a standardized ﬁeld 0.09 mm2 of the capsule
adjacent to the opening of the tube implanted was analyzed,
totaling 0.27 mm2 per implant. In each area, the total num-
ber of IC (neutrophils, lymphocytes, plasma cells, and mac-
rophages) was counted using the image analysis system at
6953 magniﬁcation. Thus, the number of ICs/mm2 was
obtained for each implant.
Interleukin-6 immunohistochemistry. For antigen retrieval,
deparafﬁnized sections were immersed in 0.001M sodium
citrate buffer pH 6.0 and maintained at 90–94C for 20 min
in a microwave oven. After a cooling-off period, the sections
were washed and the endogenous peroxidase was blocked
with 5% hydrogen peroxide for 20 min. After washings in
0.1M sodium phosphate buffer (PBS) at pH 7.2, the sections
were incubated with 2% bovine serum albumin (Sigma-
Aldrich Chemie, Germany) for 30 min. Subsequently, the sec-
tions were incubated overnight at 4C with anti-IL-6 goat
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primary antibody (Santa Cruz Biotechnology, USA), diluted
1:400. After washings in PBS, the immunoreaction was
detected by the Labeled StreptAvidin-Biotin system (LSAB-
plus Kit; Dako, USA). After incubation for 20 min at room
temperature with multilink solution containing biotinylated
mouse/rabbit/goat antibodies, the sections were washed in
PBS and subsequently were incubated with streptavidin-
peroxidase complex for 20 min at room temperature. Perox-
idase activity was revealed by Betazoid DAB (Biocare Medi-
cal, USA) for 3 min; the sections were counterstained with
Carazzi’s hematoxylin. As negative controls, the primary
antibody was replaced by non-immune serum.
Numerical density of IL-6-immunolabeled cells. The num-
ber of IL-6-immunolabeled cells per mm2 of the capsule
was counted at 6953 using an image analysis system
(Image Pro-Express 6.0, Olympus) following the methodol-
ogy previously described.27 For each tube implanted, the
IL-6 positive cells were counted in a standardized area
(0.09 mm2); in each group (n5 5), the values were divided
by the total area, and then, the number of IL-6/mm2 was
obtained.
von Kossa histochemical reaction. The von Kossa method
was used for detection of calciﬁed structures26,28 in the cap-
sule formed on the opening tube. Three sections per
implant were selected at intervals of at least 100 mm.
Deparafﬁnized sections were immersed in 5% silver nitrate
solution for 1 h; the sections were washed in distilled water
and subsequently were immersed in 5% sodium thiosulfate
for 5 min. After washings, the sections were stained by pic-
rosirius method and mounted in resinous medium. As nega-
tive control, some sections were immersed in 10% EDTA
solution and subsequently submitted to the von Kossa
method. As positive control, the sections of tibiae of young
rats were used.
Statistical analysis
The differences between the groups were statistically ana-
lyzed by the SigmaStat 2.0 software (Jandel Scientiﬁc, Sausa-
lito, CA). The data of all physicochemical tests and of the
morphometrical ﬁndings were submitted to ANOVA and
Tukey test. The signiﬁcance level accepted was p 0.05.
RESULTS
Analyses of the pH and calcium ion release
The pH solutions of the materials varied from 9.32 to 10.41
in the periods. At 1 day, statistical differences were not
found among materials; however, the pH of solutions con-
taining CS1BO was signiﬁcantly smaller in comparison
with other groups at 7, 14, and 28 days (Table I).
According to Table I, a signiﬁcant increase in the amount
of calcium released was observed from the 1 to 7 days in
all materials. The amount of calcium ion released by
CS1BO was signiﬁcantly lower in comparison with other
materials at 7, 14, and 28 days.
Radiopacity and setting time
The radiopacity of CS1OB, CS1 ZrO2micro, and CS1 ZrO2-
nano was signiﬁcantly higher than CS; differences between
the CS1OB, CS1 ZrO2micro, and CS1 ZrO2nano materials
were not statistically signiﬁcant. Statistical differences in
the initial and ﬁnal setting times were not found among
CS1 ZrO2micro, CS1 ZrO2nano, and CS1OB materials;
otherwise, the CS exhibited signiﬁcantly shorter initial
and ﬁnal setting times in comparison with other groups
(Table II).
TABLE I. Means and Standard Deviations of pH Values and Calcium Ion Release (mg/L) for the Different Materials in the
Evaluation Periods
CS CS1BO CS1ZrO2micro CS1ZrO2nano
1 Day
pH 10.36 (0.32)a 10.31 (0.29)a 10.41 (0.33)a 10.38 (0.35)a
Calcium 3.13 (1.47)a 2.73 (0.70)a 2.44 (0.43)a 2.44 (0.43)a
7 Days
pH 10.29 (0.09)a 9.66 (0.53)b 10.15 (0.39)a 10.24 (0.21)a
Calcium 11.92 (0.83)a 7.74 (1.01)b 11.00 (1.46)a 10.61 (1.26)a
14 Days
pH 9.88 (0.17)a 9.53 (0.41)b 9.84 (0.29)a 9.94 (0.22)a
Calcium 10.90 (1.83)a 9.12 (0.90)b 12.74 (2.10)a 11.77 (2.03)a
28 Days
pH 9.88 (0.06)a 9.32 (0.21)b 9.72 (0.28)a 9.97 (0.35)a
Calcium 11.61 (3.26)a 8.06 (1.32)b 9.19 (1.07)a 9.11 (1.20)a
The different superscript letters (a and b) in the lines indicate significant differences among materials (p 0.05).
TABLE II. Means and Standard Deviations of Radiopacity
(mm Al) for the Initial and Final Setting Times (in min) for
Each Material
Materials Radiopacity
Setting Time
Initial Final
CS 1.32 (0.09)a 31.0 (3.2)a 120.2 (2.4)a
CS1BO 4.45 (0.37)b 38.5 (4.3)b 167.8 (4.9)b
CS1ZrO2micro 4.12 (0.34)
b 45.5 (3.3)b 175.8 (7.0)b
CS1ZrO2nano 4.12 (0.23)
b 48.8 (5.7)b 169.0 (9.0)b
Different superscript letters (a and b) indicate statistically significant
differences (p< 0.05).
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Compression strength
In all periods, CS material exhibited the highest compression
strength values compared with other groups. The lowest
compression strength means were found in CS1BO mate-
rial; statistical differences between CS1 ZrO2micro and
CS1 ZrO2nano groups were not detected. In all groups, an
TABLE III. Means and Standard Deviations for Compressive Strength Values (in MPa) at 24 h, 7, 14, 21, and 28 Days After
Manipulation of Each Material
CS CS1BO CS1ZrO2micro CS1ZrO2nano
24 h 41.22 (3.40)a,1 10.96 (1.53)b,1 34.23 (3.47)c,1 31.50 (4.23)c,1
7 Days 49.88 (1.02)a,2 18.86 (4.10)b,2 41.06 (2.10)c,2 40.20 (2.60)c,2
14 Days 51.63 (2.70)a,2 21.05 (4.13)b,2 42.76 (2.54)c,2 41.16 (2.00)c,2
21 Days 63.29 (4.90)a,3 21.82 (3.29)b,2 48.93 (3.33)c,3 50.44 (5.49)c,3
28 Days 64.38 (2.90)a,3 27.95 (4.03)b,3 49.15 (1.51)c,3 50.56 (4.01)c,3
Different superscript letters (a–c) in the lines indicate statistically significant difference amongst groups (p<0.05).
Different superscript numbers (1–3) in the columns indicate statistically significant difference amongst periods (p< 0.05).
FIGURE 1. A–H: Light micrographs of sections showing portions of capsule adjacent to the opening of the tubes implanted (I) in the subcutaneous
tissue of the CS (A and E), CS1BO (B and F), CS1ZrO2micro (C and G), and CS1ZrO2nano (D and H) groups at 7 days (A–D) and 15 days (E–H).
A (CS): Several inflammatory cells (arrows) are seen, mainly, in the inner portion of the capsule adjacent to CS. GC, giant cell. 3200. B (CS1BO):
Numerous inflammatory cells (arrows) are distributed by throughout capsule. 3200. (C) (CS1ZrO2micro) and (D) (CS1ZrO2nano): The capsules
show several inflammatory cells (arrows). Note that in the CS1ZrO2nano group, the inflammatory cells (arrows) are present, mainly, in the inner
portion of the capsule in close juxtaposition to material (I). (BV), blood vessels. 3190. E (CS): The capsule is composed by fibroblasts (Fb) amongst
the collagen fibers (CF); the inflammatory cells (arrows) are seen in the inner portion of the capsule. 3190. (F) (CS1BO), (G) (CS1ZrO2micro),
and (H) (CS1ZrO2nano): The capsules exhibit several inflammatory cells (arrows) and various blood vessels (BV) distributed by the connective tis-
sue. 3190 (F); 3200 (G and H). H&E. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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increase in the mean values was seen in the periods of 21
and 28 days in comparison with 24 h (Table III).
Tissue reaction
Morphological ﬁndings and numerical density of
inﬂammatory cells. At 7 days, a moderate inﬂammatory
process was seen in the capsules juxtaposed to the tubes
implanted; this inﬂammatory process contained mainly lym-
phocytes and macrophages [Fig. 1(A–D)] and some multi-
nucleated giant cells [Fig. 1(A,C)]. In all groups, the highest
numerical density of ICs was veriﬁed at 7 days; a gradual
and signiﬁcant reduction in the number of ICs was observed
in the subsequent periods (Table IV). At 15 days, the ICs
were present in close juxtapotision to the materials
implanted as well as next to the blood vessels, except in the
CS1BO group; in this group, numerous ICs were still seen
dispersed by capsule [Fig. 1(E–H)]. Some multinucleated
giant cells were observed in the capsules mainly in close
contact to the materials [Fig. 1(F,H)]. On 30 day, the number
of ICs was signiﬁcantly lower in the CS1 ZrO2micro and
CS1 ZrO2nano groups in comparison with CS1BO group
(Table IV); several macrophages and plasma cells were still
present in the capsules of the CS1BO group [Fig. 2(B)].
However, the capsules juxtaposed to the CS1 ZrO2micro
and CS1 ZrO2nano did not exhibit collagen ﬁbers as well
arranged as observed in CS group [Fig. 2(A–D)]. At 60 days,
the capsules frequently exhibited typical bundles of collagen
ﬁbers among ﬁbroblasts [Fig. 2(E–H)]. In the CS1BO group,
the ICs were present mainly in the innermost portion of the
capsule [Fig. 2(F)].
According to Table IV, the highest numerical density of ICs
was veriﬁed in the capsules adjacent to CS1BO in all periods.
In all periods, statistical differences in the number of ICs were
not detected between the CS1 ZrO2micro and CS1 ZrO2nano
groups; however, these groups exhibited a signiﬁcant increase
in the number of ICs in comparison with the CS group.
Numerical density of IL-6-immunolabeled cells. In all peri-
ods, some IL-6 immunolabeled cells were present in the
capsules [Fig. 3(A–H)]. According to Table IV, the number of
immunolabeled cells was statistically higher at 7 days and,
subsequently, a signiﬁcant and gradual reduction was seen
at 15, 30, and 60 days. The highest number of IL-6 positive
cells was seen in the capsule of CS1BO group, in all peri-
ods. Immunoreaction for IL-6 was not observed in the nega-
tive control sections (data not shown).
von Kossa histochemical method. Dense von Kossa-
positive structures were often found in the innermost por-
tion of the capsules juxtaposed to the materials implanted,
in all periods [Fig. 4(B-H)]; occasionally, small von Kossa-
positive structures were dispersed by throughout capsule
[Fig. 4(A,D)]. Sections of developing long bone, used as posi-
tive control, exhibited black bone trabeculae (von Kossa-
positive) in the diaphysis. Moreover, no von Kossa-positive
structure was found in the sections used as negative control
(data not shown).
DISCUSSION
The results demonstrated that Zr2O microparticulated or
nanoparticulated provides satisfactory physicochemical
properties when added to CS. Moreover, the Zr2O added to
the CS exhibited better biological response than association
of BO to the CS.
Physicochemical analyses
The evaluated materials with addition of BO or Zr2O exhib-
ited radiopacity signiﬁcantly higher than CS and superior to
the minimum value recommended by ISO 687621 which is
in accordance with previous studies.5,6 Moreover, the means
values of calcium ions in the solutions with CS1 ZrO2micro
and CS1 ZrO2nano were statistically similar to CS, indicat-
ing, therefore, that the addition of 30% micro or nanoparti-
culated ZrO2 does not affect the release of calcium ions, as
described by other authors.7,15 Evidence suggests that ZrO2
does not react with CS, once, the reaction by-products of
the ZrO2 added to the cements did not differ of the pure
PC.15 In contrast, the BO reacts with CS forming a calcium
TABLE IV. Number of Inflammatory Cells (IC) and IL-6 Immunolabeled Cells per mm2 in the Capsule Adjacent to the Different
Materials and Control Group
CS CS1BO CS1ZrO2micro CS1ZrO2nano Control
7 Days
IC 531.3 (19.1)a,1 699.6 (6.0)b,1 621.0 (17.1)c,1 626.1 (12.5)c,1 453.9 (7.2)d,1
IL-6 404.4 (6.0)a,1 491.1 (9.2)b,1 408.8 (14.4)a,1 413.3 (14.4)a,1 371.1 (23.0)c,1
15 Days
IC 409.8 (3.3)a,2 563.4 (6.1)b,2 515.7 (11.1)c,2 514.5 (9.9)c,2 389.4 (12.4)d,2
IL-6 148.8 (20.1)a,2 200.0 (11.1)b,2 168.8 (9.2)c,2 191.1 (9.2)b,2 151.1 (18.5)a,2
30 Days
IC 374.7 (6.6)a,3 463.5 (17.7)b,3 416.4 (22.2)c,3 425.1 (26.4)c,3 368.4 (13.7)a,3
IL-6 84.4 (6.0)a,3 135.5 (14.4)b,3 102.2 (9.2)c,3 106.6 (6.0)c,3 84.4 (6.0)a,3
60 Days
IC 197.4 (13.2)a,4 272.1 (8.1)b,4 225.3 (9.0)c,4 229.8 (10.2)c,4 194.7 (16.4)a,4
IL-6 62.2 (2.8)a,4 91.1 (3.1)b,4 62.2 (2.0)a,4 82.2 (0.2)c,4 53.3 (5.4)d,4
The comparison amongst groups (p< 0.05) is indicated by different superscript (a–d) in the various lines.
The comparison amongst periods (p< 0.05) is indicated by number superscripts in the various columns.
Mean (standard deviation).
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silicate hydrate gel. Our ﬁndings showed signiﬁcant reduc-
tion in the amount of release of calcium ions and pH veri-
ﬁed in the CS1BO reinforcing the idea that BO interferes
with chemical properties of CS. There is evidence that BO
reduces the precipitation of calcium hydroxide resulting in
low alkalinity of the CS1BO solutions.9
The addition of radiopaciﬁers increased the setting time
of CS, as observed in other studies.7,14 It is possible that the
increase in the setting time caused by ZrO2 (micro and
nano) and BO added to CS may be due to the presence of
smaller amount of cement in these mixtures, affecting its
hydration and increasing the setting time.9,14 Although sig-
niﬁcant reduction in the resistance to compression was pro-
moted by ZrO2 and BO associated to CS cement, the loss of
compressive strength caused by ZrO2 was 20%, whereas
of the BO was around 65% in comparison to pure CS. The
BO promotes ﬂaws in the CS matrix formation,9 causing
increase in the porosity and solubility, and, consequently,
FIGURE 2. A–H: Light micrographs of sections showing portions of capsule adjacent to the opening of the tubes implanted (I) in the subcutane-
ous tissue of the CS (A and E), CS1BO (B and F), CS1ZrO2micro (C and G), and CS1ZrO2nano (D and H) groups at 30 days (A–D) and 60 days
(E–H). A (CS): The capsule contains various fibroblasts (Fb) amongst the collagen fiber bundles (CF); the inflammatory cells (arrows) are mainly
observed next to the blood vessels (BV). 3190. B (CS1BO): Numerous inflammatory cells (arrows) are presented by throughout of the thick
capsule. 3200. (C) (CS1ZrO2micro) and (D) (CS1ZrO2nano): The inner portions of the capsules exhibit some collagen fiber bundles (CF)
amongst the fibroblasts (Fb); inflammatory cells (arrows) are seen adjacent to the materials implanted (I) and near to the blood vessels (BV).
3200; 3180. E–H: The capsules adjacent to the materials implanted (I) exhibit several fibroblasts (Fb) amongst the collagen fiber bundles (CF);
blood vessels (BV) are also present in the connective tissue. Note that evident presence of inflammatory cells (arrows) in the capsule adjacent to
CS1BO. 3210 (E); 3190 (F–H). H&E. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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reduces the mechanical strength of the cement.8,29 In this
study, loss in the compressive strength was also veriﬁed in
the CS cement associated to 30% ZrO2. However, no inter-
ference in the compressive strength was observed in the
addition of 20% ZrO2 to PC.
10 Considering that PC provides
resistance to the material,8 it is possible that the higher
amount of PC present in the mixture could explain these
controversial ﬁndings. On the other hand, a similar mixture
to that used in this study (30% ZrO21CS) did not affect
the compressive strength of the CS14 suggesting that trade-
mark of the ZrO2 may also interfere in the reaction
mechanism.
Our results indicated that microparticulated or nanopar-
ticulated ZrO2 provides satisfactory physicochemical proper-
ties when added to the CS cement and improved the
compressive strength of the mixture when compared with
FIGURE 3. A–H: Light micrographs of sections showing portions of capsule adjacent to the opening of the tubes implanted (I) in the subcutane-
ous tissue at 7 days (A–D) and at 60 days (E–H). The sections were submitted to immunohistochemistry for detection of IL-6 and counterstained
by hematoxylin. IL-6-immunolabeling (brown–yellow color) is observed in the cells of the capsule adjacent to the different materials implanted
(I). (BV), blood vessel. 3500. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. A–H: Light micrographs of sections showing portions of capsule adjacent to the opening of the tubes implanted (I) in the subcutane-
ous tissue at 7 days (A–D) and 60 days (E–H). The sections were submitted to the von Kossa reaction and counterstained by picrosirius. Small
and dense von Kossa-positive structures (black color) are dispersed by throughout capsule (A and D). von Kossa-positive structures with
irregular-shaped are in the inner portion of the capsules (B–D, G, and H). E: A continuous layer strongly von Kossa-positive is observed in close
contact with material. F: Small and dense von Kossa-positive structures are present in the capsule surface. 3220. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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BO. However, statistical signiﬁcant differences between the
values of CS1 ZrO2 (micro and nano) regarding to setting
time and increase microhardness were not seen. These ﬁnd-
ings may be explained at least in part due to the fact that,
in this study, microparticulated CS was used. Thus, the reac-
tion of nanoparticulated ZrO2 to the microparticulated cal-
cium silicate-based material did not provide beneﬁt to the
CS in comparison with microparticulated ZrO2.
Tissue reaction
The morphological and morphometrical ﬁndings clearly
revealed that ZrO2 is a radiopaciﬁer agent, which induces
lower inﬂammatory reaction than BO. In all periods, a sig-
niﬁcant reduction in the number of ICs and IL-6 immunola-
beled cells in the capsule juxtaposed to CS associated to
ZrO2 was observed in comparison with CS1BO.
The tubes ﬁlled with materials promoted a higher
recruitment of ICs than empty tubes indicating, therefore,
that these materials may release some substances which
stimulate the migration and differentiation of these cells
such as macrophages and plasma cells, observed often in
the capsules of all materials. During the reaction of CSs,
release of hydroxil (OH2) occurs promoting in the microen-
vironment an increase in pH (pH around 10). The alkaline
pH may stimulate the recruitment of ICs and the production
of inﬂammatory cytokines and chemokines29 that promote
enhancement of leukocyte adhesion to endothelial walls,
potentiation of neutrophils, and differentiation of plasma
cell.30,31 Thus, the elevated pH exhibited by CS group may
be responsible, at least in part, for the high number of ICs
observed at 7 days.
The inﬂammatory process involves a complex and coor-
dinated cascade of cellular and molecular events that culmi-
nate with production and release of several cytokines.32–34
Among these cytokines, IL-6 is a proinﬂammatory cytokine
that may activate and modulate speciﬁc cells and, therefore,
exerts an important role in the inﬂammatory reaction34 and
in the bone resorption.35 Our ﬁndings revealed that the
radiopaciﬁer agents promoted a signiﬁcant increase in the
number of IL-6 immunolabeled cells in the capsules. How-
ever, this increase was signiﬁcantly higher in the CS1BO in
comparison with CS1 ZrO2. There is strong evidence that
IL-6 may stimulate the production of matrix metalloprotei-
nases leading to tissue degradation.36 Thus, the gradual and
signiﬁcant reduction in the IL-6 immunolabeled cells sug-
gests that the capsules are undergoing an intense remodel-
ing process in the initial periods. In addition, the presence
of well-oriented collagen ﬁbers bundles in the capsules indi-
cates that initial inﬂammatory reaction was almost totally
replaced, in the period of 60 days, by a dense connective
tissue.
Considering that biocompatibility of the materials
depends on the components released and our results
revealed that BO associated to CS promoted the highest
inﬂammatory reaction and IL-6 immunolabeled cells, it is
possible that the BO acts as an irritant substance. It has
been demonstrated that the level of zirconium released in
solution is smaller in comparison with the bismuth indicat-
ing that the association of ZrO2 to the PC is more stable
than the BO added to the PC.15
The sections submitted to von Kossa method exhibited
black structures in the capsule adjacent to the tubes ﬁlled
with the cements, with pattern similar to von Kossa-positive
calciﬁed structures described by other authors.26,28,37 In
addition, the sections of long bone from newborn rats used
as positive control showed typical trabeculae bone positive
to von Kossa, that is, in black color. Thus, these structures
may constitute globules containing calcium that were possi-
bly released by CSs. Moreover, von Kossa positive structures
were never seen in the capsule adjacent to the empty tubes
reinforcing the concept that CS cements are responsible for
formation of these von Kossa-positive structures. The depo-
sition of the calciﬁed structures has been reported in
response to PC and MTA implanted in the subcutaneous tis-
sue.26 It is known that CSs reaction give rise to the calcium
silicate hydrated gel and calcium hydroxide.9 Thus, likewise
calcium hydroxide, the CS may release calcium ions as
shown in this study. The calcium ions can react with car-
bonate dioxide in the tissues giving rise to calcite crystals.
The calcite crystals act as a calciﬁcation nucleus and, there-
fore, could facilitate the mineralization process.38,39 In fact,
MTA induced bone-like tissue formation in perforation of
pulp chamber ﬂoor experimentally created in rat molars.2
Moreover, osteopontin was detected in ﬁbroblasts of capsu-
les surrounding the MTA and PC implanted in the subcuta-
neous.26 Considering that osteopontin is a glycoprotein
highly expressed in mineralized tissues as well as pathologic
calciﬁcation sites of soft tissues,40 it has been suggested
that MTA and PC could stimulate mesenchymal cells of sub-
cutaneous tissue to express the osteoblast-like phenotype.26
CONCLUSION
The present ﬁndings indicate that the association of micro-
particulated or nanoparticulated ZrO2 provides satisfactory
physicochemical and biological properties to the CS. The
similar tissue reaction promoted by microparticulated and
nanoparticulated ZrO2 reinforces the idea that ZrO2 may not
interfere in the hydration reaction of CS. So, ZrO2 may be a
good alternative for use as radiopacifying agent in substitu-
tion to BO. However, the addition of nanoparticulated radio-
paciﬁer did not improve the physicochemical and biological
properties of CS when compared with microparticulated
ZrO2.
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